| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | GPHN FLNA FLNB DLG5 KLHL1 EML4 APC2 DYRK1A GBP1 CLSTN2 ACTR3B SHROOM2 EML3 RAB10 TIAM1 KIF3C PLEKHH2 SCIN | 9.06e-06 | 1099 | 101 | 18 | GO:0008092 |
| GeneOntologyMolecularFunction | acetate-CoA ligase activity | 1.51e-04 | 4 | 101 | 2 | GO:0003987 | |
| GeneOntologyMolecularFunction | cadherin binding | 3.26e-04 | 339 | 101 | 8 | GO:0045296 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 3.60e-04 | 120 | 101 | 5 | GO:0008013 | |
| GeneOntologyCellularComponent | dendrite | DAB2IP GPHN FLNA KLHL1 DYRK1A CLSTN2 GRIK5 DIP2A IGF2BP1 SLC8A3 TIAM1 CPEB4 XRN1 LRP1 DLG3 KIF3C ATP2B1 | 8.23e-07 | 858 | 102 | 17 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | DAB2IP GPHN FLNA KLHL1 DYRK1A CLSTN2 GRIK5 DIP2A IGF2BP1 SLC8A3 TIAM1 CPEB4 XRN1 LRP1 DLG3 KIF3C ATP2B1 | 8.50e-07 | 860 | 102 | 17 | GO:0097447 |
| GeneOntologyCellularComponent | anchoring junction | JCAD FLNA FLNB DLG5 CDC42BPA PCDHB5 LCP2 SHROOM2 RAB10 SLC8A3 HMCN1 TIAM1 AHNAK LRP1 DLG3 SCIN CDH4 RPL8 | 1.05e-06 | 976 | 102 | 18 | GO:0070161 |
| GeneOntologyCellularComponent | somatodendritic compartment | DAB2IP GPHN FLNA FLNB KLHL1 DYRK1A CLSTN2 GRIK5 SHROOM2 TXNRD1 DIP2A IGF2BP1 SLC8A3 TIAM1 CPEB4 XRN1 LRP1 DLG3 KIF3C ATP2B1 | 1.69e-06 | 1228 | 102 | 20 | GO:0036477 |
| GeneOntologyCellularComponent | cell body | DAB2IP GPHN FLNA FLNB KLHL1 GRIK5 SHROOM2 TXNRD1 IGF2BP1 SLC8A3 TIAM1 XRN1 LRP1 DLG3 KIF3C ATP2B1 ALK | 2.43e-06 | 929 | 102 | 17 | GO:0044297 |
| GeneOntologyCellularComponent | neuronal cell body | DAB2IP GPHN FLNA FLNB KLHL1 GRIK5 SHROOM2 TXNRD1 IGF2BP1 SLC8A3 TIAM1 XRN1 LRP1 DLG3 KIF3C ATP2B1 | 2.77e-06 | 835 | 102 | 16 | GO:0043025 |
| GeneOntologyCellularComponent | cell-cell junction | JCAD FLNA DLG5 CDC42BPA PCDHB5 LCP2 SHROOM2 RAB10 HMCN1 TIAM1 AHNAK DLG3 CDH4 | 6.04e-06 | 591 | 102 | 13 | GO:0005911 |
| GeneOntologyCellularComponent | postsynaptic density | 7.18e-05 | 451 | 102 | 10 | GO:0014069 | |
| GeneOntologyCellularComponent | adherens junction | 8.17e-05 | 212 | 102 | 7 | GO:0005912 | |
| GeneOntologyCellularComponent | asymmetric synapse | 1.14e-04 | 477 | 102 | 10 | GO:0032279 | |
| GeneOntologyCellularComponent | actin cytoskeleton | FLNA FLNB CDC42BPA SEPTIN9 APC2 DYRK1A GBP1 SHROOM2 AHNAK PLEKHH2 SCIN | 1.17e-04 | 576 | 102 | 11 | GO:0015629 |
| GeneOntologyCellularComponent | postsynapse | GPHN FLNA DLG5 APC2 CLSTN2 GRIK5 DIP2A IGF2BP1 SLC8A3 TIAM1 CPEB4 LRP1 DLG3 ATP2B1 RPL8 | 1.22e-04 | 1018 | 102 | 15 | GO:0098794 |
| GeneOntologyCellularComponent | postsynaptic specialization | 1.75e-04 | 503 | 102 | 10 | GO:0099572 | |
| GeneOntologyCellularComponent | growth cone | 2.00e-04 | 245 | 102 | 7 | GO:0030426 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 2.40e-04 | 523 | 102 | 10 | GO:0098984 | |
| GeneOntologyCellularComponent | site of polarized growth | 2.43e-04 | 253 | 102 | 7 | GO:0030427 | |
| GeneOntologyCellularComponent | microtubule | EML4 SEPTIN9 APC2 DYRK1A SHROOM2 EML3 SLC8A3 TIAM1 KIF3C CFAP53 | 2.79e-04 | 533 | 102 | 10 | GO:0005874 |
| GeneOntologyCellularComponent | distal axon | 2.80e-04 | 435 | 102 | 9 | GO:0150034 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 4.59e-04 | 201 | 102 | 6 | GO:0099634 | |
| GeneOntologyCellularComponent | cell cortex | 4.69e-04 | 371 | 102 | 8 | GO:0005938 | |
| GeneOntologyCellularComponent | fibrillar center | 1.01e-03 | 156 | 102 | 5 | GO:0001650 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 1.04e-03 | 157 | 102 | 5 | GO:0098839 | |
| GeneOntologyCellularComponent | dendritic spine | 1.21e-03 | 242 | 102 | 6 | GO:0043197 | |
| GeneOntologyCellularComponent | insulin-responsive compartment | 1.26e-03 | 11 | 102 | 2 | GO:0032593 | |
| GeneOntologyCellularComponent | axon | DAB2IP FLNA DYRK1A GRIK5 IGF2BP1 SLC8A3 TIAM1 CPEB4 LRP1 DLG3 KIF3C ALK | 1.33e-03 | 891 | 102 | 12 | GO:0030424 |
| GeneOntologyCellularComponent | neuron spine | 1.34e-03 | 247 | 102 | 6 | GO:0044309 | |
| GeneOntologyCellularComponent | axonal growth cone | 1.38e-03 | 45 | 102 | 3 | GO:0044295 | |
| GeneOntologyCellularComponent | supramolecular fiber | FLNA FLNB EML4 SEPTIN9 APC2 DYRK1A SHROOM2 EML3 SLC8A3 TIAM1 AHNAK KIF3C CFAP53 AHNAK2 | 1.74e-03 | 1179 | 102 | 14 | GO:0099512 |
| GeneOntologyCellularComponent | RNA polymerase I complex | 1.78e-03 | 13 | 102 | 2 | GO:0005736 | |
| GeneOntologyCellularComponent | supramolecular polymer | FLNA FLNB EML4 SEPTIN9 APC2 DYRK1A SHROOM2 EML3 SLC8A3 TIAM1 AHNAK KIF3C CFAP53 AHNAK2 | 1.85e-03 | 1187 | 102 | 14 | GO:0099081 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | JCAD FLNA SEPTIN9 APC2 GBP1 RAB40A RAB10 IGF2BP1 SLC8A3 CPEB4 RAB40AL LRP1 | 1.98e-03 | 934 | 102 | 12 | GO:0048471 |
| GeneOntologyCellularComponent | postsynaptic membrane | 3.71e-03 | 405 | 102 | 7 | GO:0045211 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | FLNA EML4 SEPTIN9 APC2 DYRK1A SHROOM2 EML3 SLC8A3 TIAM1 KIF3C CFAP53 | 4.41e-03 | 899 | 102 | 11 | GO:0099513 |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 4.57e-03 | 137 | 102 | 4 | GO:0019897 | |
| GeneOntologyCellularComponent | costamere | 5.11e-03 | 22 | 102 | 2 | GO:0043034 | |
| Domain | PDZ | 1.07e-05 | 141 | 100 | 7 | PF00595 | |
| Domain | PDZ | 1.47e-05 | 148 | 100 | 7 | SM00228 | |
| Domain | - | 1.61e-05 | 150 | 100 | 7 | 2.30.42.10 | |
| Domain | PDZ | 1.68e-05 | 151 | 100 | 7 | PS50106 | |
| Domain | PDZ | 1.75e-05 | 152 | 100 | 7 | IPR001478 | |
| Domain | HELP | 4.20e-04 | 6 | 100 | 2 | PF03451 | |
| Domain | HELP | 4.20e-04 | 6 | 100 | 2 | IPR005108 | |
| Domain | Cadherin | 4.31e-04 | 118 | 100 | 5 | IPR002126 | |
| Domain | Calx_beta | 9.97e-04 | 9 | 100 | 2 | IPR003644 | |
| Domain | Calx-beta | 9.97e-04 | 9 | 100 | 2 | PF03160 | |
| Domain | IG_FLMN | 1.24e-03 | 10 | 100 | 2 | SM00557 | |
| Domain | Filamin | 1.51e-03 | 11 | 100 | 2 | PF00630 | |
| Domain | FILAMIN_REPEAT | 1.51e-03 | 11 | 100 | 2 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 1.51e-03 | 11 | 100 | 2 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 1.51e-03 | 11 | 100 | 2 | IPR017868 | |
| Domain | P-loop_NTPase | DLG5 RTEL1 SEPTIN9 GBP1 RAB40A RAB10 ERAL1 RAB40AL DLG3 KIF3C DDX39A DDX39B | 1.90e-03 | 848 | 100 | 12 | IPR027417 |
| Domain | - | DLG5 RTEL1 SEPTIN9 GBP1 RAB40A RAB10 ERAL1 RAB40AL DLG3 DDX39A DDX39B | 2.14e-03 | 746 | 100 | 11 | 3.40.50.300 |
| Domain | CADHERIN_1 | 3.19e-03 | 113 | 100 | 4 | PS00232 | |
| Domain | Cadherin | 3.19e-03 | 113 | 100 | 4 | PF00028 | |
| Domain | CADHERIN_2 | 3.29e-03 | 114 | 100 | 4 | PS50268 | |
| Domain | - | 3.29e-03 | 114 | 100 | 4 | 2.60.40.60 | |
| Domain | CA | 3.40e-03 | 115 | 100 | 4 | SM00112 | |
| Domain | Cadherin-like | 3.50e-03 | 116 | 100 | 4 | IPR015919 | |
| Domain | Pyr_redox_2 | 4.57e-03 | 19 | 100 | 2 | PF07992 | |
| Domain | SOCS | 5.06e-03 | 20 | 100 | 2 | SM00253 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | FLNA FLNB DLG5 RAPGEF6 ESYT1 POLH LARP1 JMJD1C AHNAK XRN1 AHNAK2 | 3.04e-10 | 256 | 103 | 11 | 33397691 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SETD1A FLNA FLNB EML4 USP11 ESYT1 SEPTIN9 MCCC1 POLR1G MIDEAS POLR1E ERAL1 AHNAK XRN1 DDX39A NOP2 ATP2B1 BAG6 DDX39B RPL8 AHNAK2 | 4.08e-10 | 1353 | 103 | 21 | 29467282 |
| Pubmed | GPHN FLNA FLNB VWF SELENBP1 SEPTIN9 DYRK1A LARP1 ACTR3B SHROOM2 RAB10 DIP2A HECW2 CPEB4 XRN1 DLG3 ATP2B1 DDX39B RPL8 CPSF7 | 6.72e-09 | 1431 | 103 | 20 | 37142655 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | DAB2IP JCAD FLNA FLNB DLG5 ESYT1 SEPTIN9 LARP1 RAB10 AHNAK XRN1 ATP2B1 DDX39B | 1.35e-08 | 565 | 103 | 13 | 25468996 |
| Pubmed | FLNA DLG5 FOXK2 CDC42BPA EML4 ESYT1 SEPTIN9 LARP1 MIDEAS RAB10 IGF2BP1 TSR1 ERAL1 AHNAK CPEB4 NOP2 ALK DDX39B CPSF7 | 1.94e-08 | 1371 | 103 | 19 | 36244648 | |
| Pubmed | SETD1A FLNA FLNB EML4 ESYT1 SEPTIN9 LARP1 IGF2BP1 TSR1 NOP2 BAG6 DDX39B RPL8 CPSF7 | 2.53e-08 | 711 | 103 | 14 | 33022573 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | FLNA FLNB ESYT1 MCCC1 POLR1G MIDEAS JMJD1C RAB10 TSR1 POLR1E AHNAK ATP6V1C2 NOP2 DDX39B RPL8 CPSF7 | 3.60e-08 | 989 | 103 | 16 | 36424410 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | GPHN JCAD DLG5 RAPGEF6 CDC42BPA ESYT1 DYRK1A LARP1 MCCC1 TIAM1 AHNAK XRN1 ATP2B1 GEN1 AHNAK2 | 3.85e-08 | 861 | 103 | 15 | 36931259 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | FLNA FLNB SELENBP1 ESYT1 SEPTIN9 LARP1 CLSTN2 MCCC1 TXNRD1 RAB10 AHNAK DDX39A RPL8 AHNAK2 | 1.20e-07 | 807 | 103 | 14 | 30575818 |
| Pubmed | 1.25e-07 | 360 | 103 | 10 | 33111431 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | FLNA CCDC174 EML4 SEPTIN9 POLH LARP1 MCCC1 MIDEAS JMJD1C IGF2BP1 AHNAK NOP2 ALK DDX39B CPSF7 | 1.45e-07 | 954 | 103 | 15 | 36373674 |
| Pubmed | FLNB DLG5 CDC42BPA ESYT1 SEPTIN9 LARP1 ATE1 JMJD1C RAB10 AHNAK XRN1 ATP2B1 RPL8 | 1.84e-07 | 708 | 103 | 13 | 39231216 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | GPHN FLNA FLNB FOXK2 USP11 ESYT1 ATE1 IGF2BP1 PTPN9 ERAL1 XRN1 LRP1 NOP2 ATP2B1 BAG6 | 1.89e-07 | 974 | 103 | 15 | 28675297 |
| Pubmed | DAB2IP GPHN JCAD FLNA FLNB CDC42BPA SEPTIN9 MCCC1 ACTR3B ATE1 SHROOM2 CPEB4 XRN1 DLG3 DDX39B RPL8 | 2.44e-07 | 1139 | 103 | 16 | 36417873 | |
| Pubmed | 2.51e-07 | 295 | 103 | 9 | 26209609 | ||
| Pubmed | FLNA CCDC174 SEPTIN9 MCCC1 JMJD1C IGF2BP1 AHNAK AHNAK2 CPSF7 | 2.74e-07 | 298 | 103 | 9 | 30737378 | |
| Pubmed | DAB2IP GPHN FLNA FLNB FOXK2 SEPTIN9 LARP1 POLR1G IGF2BP1 NOP2 BAG6 | 3.13e-07 | 503 | 103 | 11 | 16964243 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | FLNA FLNB SEPTIN9 RAB10 IGF2BP1 BBS7 ERAL1 AHNAK SCIN NOP2 ATP2B1 BAG6 DDX39B RPL8 CPSF7 | 3.57e-07 | 1024 | 103 | 15 | 24711643 |
| Pubmed | Analysis of HIV-1 Gag protein interactions via biotin ligase tagging. | 5.82e-07 | 54 | 103 | 5 | 25631074 | |
| Pubmed | 6.42e-07 | 330 | 103 | 9 | 32529326 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 6.75e-07 | 332 | 103 | 9 | 32786267 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | GPHN FLNA RAPGEF6 ESYT1 SEPTIN9 LARP1 MCCC1 IGF2BP1 AHNAK XRN1 SCIN NOP2 RPL8 AHNAK2 | 6.92e-07 | 934 | 103 | 14 | 33916271 |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | FLNA FLNB SELENBP1 USP11 DYRK1A LARP1 PTPN9 TSR1 POLR1E ERAL1 NOP2 DDX39B | 7.34e-07 | 670 | 103 | 12 | 22990118 |
| Pubmed | 8.22e-07 | 340 | 103 | 9 | 24332808 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | FLNA FLNB DLG5 SEPTIN9 LARP1 POLR1G RAB10 IGF2BP1 TSR1 AHNAK DDX39A NOP2 DDX39B RPL8 | 8.35e-07 | 949 | 103 | 14 | 36574265 |
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 25740311 | ||
| Pubmed | FLNA FOXK2 CCDC174 SEPTIN9 LARP1 MIDEAS JMJD1C TXNRD1 RAB10 IGF2BP1 DDX39A NOP2 BAG6 MNT CPSF7 | 9.05e-07 | 1103 | 103 | 15 | 34189442 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DAB2IP SETD1A FLNA RAPGEF6 FOXK2 CDC42BPA ESYT1 HECTD4 DYRK1A EML3 PIM3 DIP2A AHNAK AHNAK2 BAHCC1 | 9.26e-07 | 1105 | 103 | 15 | 35748872 |
| Pubmed | 9.76e-07 | 255 | 103 | 8 | 15324660 | ||
| Pubmed | FLNA FLNB LARP1 TXNRD1 IGF2BP1 TSR1 ERAL1 LRP1 SCIN NOP2 ATP2B1 BAG6 DDX39B CPSF7 | 1.09e-06 | 971 | 103 | 14 | 33306668 | |
| Pubmed | 1.40e-06 | 8 | 103 | 3 | 12475935 | ||
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 1.42e-06 | 268 | 103 | 8 | 33024031 | |
| Pubmed | 1.47e-06 | 118 | 103 | 6 | 30979931 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | GPHN FOXN1 FOXK2 USP11 ESYT1 DYRK1A LARP1 JMJD1C ERAL1 LRP1 DDX39A ATP2B1 MNT | 1.57e-06 | 857 | 103 | 13 | 25609649 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | FLNA EML4 SEPTIN9 LARP1 MCCC1 AHNAK CPEB4 XRN1 NOP2 GEN1 DDX39B AHNAK2 | 1.64e-06 | 724 | 103 | 12 | 36232890 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | SETD1A FLNA ESYT1 LARP1 MCCC1 POLR1G RAB10 IGF2BP1 TSR1 POLR1E AHNAK PKLR DDX39A NOP2 DDX39B RPL8 | 1.67e-06 | 1318 | 103 | 16 | 30463901 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | FLNA FLNB ESYT1 SEPTIN9 LARP1 RAB10 IGF2BP1 AHNAK XRN1 CPSF7 | 2.38e-06 | 498 | 103 | 10 | 36634849 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 2.48e-06 | 202 | 103 | 7 | 33005030 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 2.99e-06 | 398 | 103 | 9 | 35016035 | |
| Pubmed | 3.05e-06 | 399 | 103 | 9 | 35987950 | ||
| Pubmed | FLNA FLNB EML4 ESYT1 IGF2BP1 ERAL1 NOP2 BAG6 DDX39B RPL8 CPSF7 | 3.15e-06 | 638 | 103 | 11 | 33239621 | |
| Pubmed | 3.87e-06 | 216 | 103 | 7 | 31519766 | ||
| Pubmed | 4.09e-06 | 11 | 103 | 3 | 36579465 | ||
| Pubmed | 4.45e-06 | 418 | 103 | 9 | 34709266 | ||
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 4.78e-06 | 316 | 103 | 8 | 31665637 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | FLNA FLNB LARP1 IGF2BP1 ERAL1 CPEB4 XRN1 DDX39A NOP2 DDX39B RPL8 CPSF7 | 4.98e-06 | 807 | 103 | 12 | 22681889 |
| Pubmed | FLNA CDC42BPA ESYT1 SEPTIN9 LARP1 IGF2BP1 TSR1 POLR1E AHNAK KIF3C NOP2 RPL8 | 5.11e-06 | 809 | 103 | 12 | 32129710 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | GPHN FLNA FLNB ESYT1 DYRK1A MCCC1 RAB10 AHNAK CPEB4 LRP1 KIF3C ATP2B1 BAG6 MNT RPL8 CPSF7 | 5.67e-06 | 1451 | 103 | 16 | 30550785 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | EML4 USP11 PCDHB5 DYRK1A LARP1 ACTR3B JMJD1C EML3 RAB10 IGF2BP1 TIAM1 TSR1 POLR1E DLG3 BAG6 | 5.78e-06 | 1284 | 103 | 15 | 17353931 |
| Pubmed | Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. | 6.14e-06 | 327 | 103 | 8 | 15592455 | |
| Pubmed | 6.36e-06 | 152 | 103 | 6 | 34299191 | ||
| Pubmed | 6.36e-06 | 152 | 103 | 6 | 16009940 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 6.72e-06 | 440 | 103 | 9 | 34244565 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | FLNA FLNB FOXK2 USP11 SEPTIN9 LARP1 RAB10 IGF2BP1 TSR1 AHNAK BAG6 DDX39B RPL8 CPSF7 | 7.61e-06 | 1149 | 103 | 14 | 35446349 |
| Pubmed | Cell cycle-dependent palmitoylation of protocadherin 7 by ZDHHC5 promotes successful cytokinesis. | 8.24e-06 | 159 | 103 | 6 | 36762613 | |
| Pubmed | FLNA FLNB ESYT1 SEPTIN9 RAB10 IGF2BP1 AHNAK BAG6 DDX39B RPL8 CPSF7 | 8.31e-06 | 707 | 103 | 11 | 19738201 | |
| Pubmed | 8.54e-06 | 160 | 103 | 6 | 23375831 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 27811184 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 21356191 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 16949217 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 32876329 | ||
| Pubmed | Malignant pleural mesothelioma with an EML4-ALK fusion: Expect the unexpected! | 8.69e-06 | 2 | 103 | 2 | 35074700 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 25028527 | ||
| Pubmed | EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer. | 8.69e-06 | 2 | 103 | 2 | 18594010 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 25735977 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 38377942 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 24643514 | ||
| Pubmed | EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with wild-type EGFR. | 8.69e-06 | 2 | 103 | 2 | 22124476 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 26704814 | ||
| Pubmed | EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues. | 8.69e-06 | 2 | 103 | 2 | 19147828 | |
| Pubmed | Targeting stemness is an effective strategy to control EML4-ALK+ non-small cell lung cancer cells. | 8.69e-06 | 2 | 103 | 2 | 26517679 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 24346098 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 20610707 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 34661367 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 30236141 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 25144242 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 17635842 | ||
| Pubmed | Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts. | 8.69e-06 | 2 | 103 | 2 | 18927303 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 18242762 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 38225262 | ||
| Pubmed | Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer. | 8.69e-06 | 2 | 103 | 2 | 18593892 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 27507192 | ||
| Pubmed | PAF49: An RNA Polymerase I subunit essential for rDNA transcription and stabilization of PAF53. | 8.69e-06 | 2 | 103 | 2 | 37356716 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 11336782 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 33649519 | ||
| Pubmed | EML4-ALK fusion transcript is not found in gastrointestinal and breast cancers. | 8.69e-06 | 2 | 103 | 2 | 18414414 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 34783600 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 27943404 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 22849406 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 32563740 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 24388371 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 29628502 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 15007166 | ||
| Pubmed | New insights into anaplastic lymphoma kinase-positive nonsmall cell lung cancer. | 8.69e-06 | 2 | 103 | 2 | 29199691 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 29517858 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 27060609 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 20833135 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 29184034 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 24633422 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 20573985 | ||
| Interaction | HDAC1 interactions | FLNA FLNB RAPGEF6 FOXK2 CDC42BPA EML4 USP11 POLH MCCC1 POLR1G MIDEAS JMJD1C PHF1 TSR1 POLR1E AHNAK XRN1 KDM4A MNT BAHCC1 | 4.30e-07 | 1108 | 100 | 20 | int:HDAC1 |
| Interaction | POTED interactions | 4.72e-07 | 4 | 100 | 3 | int:POTED | |
| Interaction | PHLPP1 interactions | FLNA FLNB DLG5 RAPGEF6 ESYT1 POLH LARP1 JMJD1C AHNAK XRN1 AHNAK2 | 8.13e-07 | 333 | 100 | 11 | int:PHLPP1 |
| Interaction | TOP3B interactions | DAB2IP SETD1A FLNA RAPGEF6 FOXK2 CDC42BPA RTEL1 ESYT1 HECTD4 DYRK1A EML3 PIM3 DIP2A IGF2BP1 AHNAK CPEB4 XRN1 KDM4A NOP2 DDX39B AHNAK2 BAHCC1 | 2.42e-06 | 1470 | 100 | 22 | int:TOP3B |
| Interaction | SIRT6 interactions | SETD1A FLNA FLNB FOXK2 USP11 ESYT1 HECTD4 DYRK1A LARP1 NOP2 BAG6 DDX39B RPL8 | 1.37e-05 | 628 | 100 | 13 | int:SIRT6 |
| Interaction | KIF20A interactions | FLNA FLNB POLH APC2 HECTD4 DYRK1A LARP1 POLR1G RAB10 IGF2BP1 AHNAK XRN1 SCIN NOP2 DDX39B RPL8 AHNAK2 | 1.54e-05 | 1052 | 100 | 17 | int:KIF20A |
| Interaction | MEX3A interactions | 2.12e-05 | 384 | 100 | 10 | int:MEX3A | |
| Interaction | POTEC interactions | 3.27e-05 | 13 | 100 | 3 | int:POTEC | |
| Interaction | SUMO2 interactions | FLNA FLNB SELENBP1 USP11 EML3 TSR1 AHNAK DDX39A NOP2 DDX39B AHNAK2 CPSF7 | 3.62e-05 | 591 | 100 | 12 | int:SUMO2 |
| Interaction | KCTD13 interactions | GPHN FLNA FLNB VWF SEPTIN9 DYRK1A LARP1 ACTR3B SHROOM2 RAB10 DIP2A HECW2 CPEB4 XRN1 DLG3 ATP2B1 DDX39B RPL8 CPSF7 | 4.86e-05 | 1394 | 100 | 19 | int:KCTD13 |
| Interaction | LIMA1 interactions | 5.40e-05 | 429 | 100 | 10 | int:LIMA1 | |
| Interaction | TARDBP interactions | FLNB DYRK1A LARP1 TSR1 AHNAK XRN1 SCIN NOP2 BAG6 DDX39B RPL8 | 5.42e-05 | 520 | 100 | 11 | int:TARDBP |
| Interaction | LYN interactions | DAB2IP DLG5 CDC42BPA ESYT1 SEPTIN9 LCP2 PIM3 TIAM1 TSR1 PLEKHH2 ATP2B1 DDX39B AHNAK2 | 5.64e-05 | 720 | 100 | 13 | int:LYN |
| Interaction | SINHCAF interactions | 5.75e-05 | 135 | 100 | 6 | int:SINHCAF | |
| Interaction | FZR1 interactions | FLNA FLNB DYRK1A LARP1 TXNRD1 IGF2BP1 TSR1 ERAL1 HECW2 LRP1 SCIN NOP2 ATP2B1 BAG6 DDX39B RPL8 CPSF7 | 6.01e-05 | 1172 | 100 | 17 | int:FZR1 |
| Interaction | LRRC31 interactions | 7.32e-05 | 205 | 100 | 7 | int:LRRC31 | |
| Interaction | NDN interactions | 8.49e-05 | 453 | 100 | 10 | int:NDN | |
| Interaction | HDAC2 interactions | FLNA FOXK2 CCDC174 EML4 USP11 SEPTIN9 MCCC1 MIDEAS JMJD1C PHF1 IGF2BP1 AHNAK AHNAK2 CPSF7 | 9.26e-05 | 865 | 100 | 14 | int:HDAC2 |
| Interaction | YAP1 interactions | GPHN JCAD SETD1A FLNA FLNB RAPGEF6 APC2 LARP1 MIDEAS JMJD1C TSR1 HECW2 AHNAK PKLR DDX39B CPSF7 | 9.35e-05 | 1095 | 100 | 16 | int:YAP1 |
| Interaction | KCNA3 interactions | FLNB DLG5 CDC42BPA ESYT1 SEPTIN9 LARP1 ATE1 JMJD1C RAB10 AHNAK XRN1 DDX39A ATP2B1 RPL8 | 9.96e-05 | 871 | 100 | 14 | int:KCNA3 |
| Interaction | AATF interactions | 1.06e-04 | 376 | 100 | 9 | int:AATF | |
| Interaction | CDH1 interactions | DAB2IP JCAD FLNA FLNB DLG5 ESYT1 SEPTIN9 LARP1 RAB10 AHNAK XRN1 ATP2B1 DDX39B | 1.08e-04 | 768 | 100 | 13 | int:CDH1 |
| Interaction | SMC5 interactions | FLNA CCDC174 EML4 SEPTIN9 POLH LARP1 MCCC1 MIDEAS JMJD1C IGF2BP1 AHNAK NOP2 ALK DDX39B CPSF7 | 1.19e-04 | 1000 | 100 | 15 | int:SMC5 |
| Interaction | YWHAG interactions | DAB2IP GPHN JCAD FLNA DLG5 RAPGEF6 CDC42BPA ESYT1 HECTD4 DYRK1A LARP1 SHROOM2 EML3 TIAM1 GEN1 DDX39B AHNAK2 | 1.30e-04 | 1248 | 100 | 17 | int:YWHAG |
| Interaction | OBSL1 interactions | FLNA FLNB SEPTIN9 DYRK1A POLR1G MIDEAS IGF2BP1 POLR1E AHNAK SCIN NOP2 DDX39B RPL8 CPSF7 | 1.44e-04 | 902 | 100 | 14 | int:OBSL1 |
| Interaction | CDK9 interactions | FLNA FLNB CDC42BPA EML4 SEPTIN9 LARP1 IGF2BP1 DDX39A NOP2 ALK AHNAK2 CPSF7 | 1.47e-04 | 685 | 100 | 12 | int:CDK9 |
| Interaction | DXO interactions | 1.48e-04 | 21 | 100 | 3 | int:DXO | |
| Interaction | JSRP1 interactions | 1.48e-04 | 21 | 100 | 3 | int:JSRP1 | |
| Interaction | ABCA1 interactions | 1.49e-04 | 54 | 100 | 4 | int:ABCA1 | |
| Interaction | C11orf52 interactions | 1.60e-04 | 311 | 100 | 8 | int:C11orf52 | |
| Interaction | ISG15 interactions | FLNA FLNB DYRK1A GBP1 TXNRD1 AHNAK DDX39A ATP2B1 DDX39B AHNAK2 | 1.72e-04 | 494 | 100 | 10 | int:ISG15 |
| Interaction | RAPGEF2 interactions | 1.77e-04 | 105 | 100 | 5 | int:RAPGEF2 | |
| Interaction | FBXL4 interactions | 1.85e-04 | 106 | 100 | 5 | int:FBXL4 | |
| Interaction | PPP1R12A interactions | 2.03e-04 | 322 | 100 | 8 | int:PPP1R12A | |
| Interaction | OTUD1 interactions | 2.04e-04 | 170 | 100 | 6 | int:OTUD1 | |
| Interaction | AGR2 interactions | FLNA FLNB SELENBP1 ESYT1 SEPTIN9 LARP1 CLSTN2 MCCC1 TXNRD1 RAB10 AHNAK DDX39A RPL8 AHNAK2 | 2.06e-04 | 934 | 100 | 14 | int:AGR2 |
| Interaction | ICE1 interactions | 2.11e-04 | 59 | 100 | 4 | int:ICE1 | |
| Interaction | CHD4 interactions | SETD1A FOXK2 EML4 USP11 LARP1 PHF1 IGF2BP1 TSR1 AHNAK XRN1 DDX39A NOP2 DDX39B RPL8 | 2.16e-04 | 938 | 100 | 14 | int:CHD4 |
| Interaction | WDHD1 interactions | 2.54e-04 | 177 | 100 | 6 | int:WDHD1 | |
| Interaction | FN1 interactions | FLNA FLNB ESYT1 SEPTIN9 DYRK1A CFB RAB10 IGF2BP1 AHNAK BAG6 DDX39B RPL8 CPSF7 | 2.85e-04 | 848 | 100 | 13 | int:FN1 |
| Interaction | PHF21A interactions | 3.10e-04 | 343 | 100 | 8 | int:PHF21A | |
| Interaction | GP1BA interactions | 3.18e-04 | 27 | 100 | 3 | int:GP1BA | |
| Interaction | NAA40 interactions | GPHN FLNA RAPGEF6 ESYT1 SEPTIN9 LARP1 MCCC1 IGF2BP1 AHNAK XRN1 SCIN NOP2 RPL8 AHNAK2 | 3.30e-04 | 978 | 100 | 14 | int:NAA40 |
| Interaction | WDR5 interactions | SETD1A FLNA FLNB EML4 ESYT1 SEPTIN9 LARP1 IGF2BP1 TSR1 POLR1E NOP2 BAG6 DDX39B RPL8 CPSF7 | 3.37e-04 | 1101 | 100 | 15 | int:WDR5 |
| Interaction | DYNLL2 interactions | 3.39e-04 | 263 | 100 | 7 | int:DYNLL2 | |
| Interaction | YWHAH interactions | DAB2IP JCAD DLG5 RAPGEF6 CDC42BPA ESYT1 HECTD4 DYRK1A LARP1 EML3 TIAM1 AHNAK XRN1 GEN1 AHNAK2 | 3.40e-04 | 1102 | 100 | 15 | int:YWHAH |
| Interaction | GBF1 interactions | 3.53e-04 | 442 | 100 | 9 | int:GBF1 | |
| Interaction | SEPTIN9 interactions | 3.55e-04 | 265 | 100 | 7 | int:SEPTIN9 | |
| Interaction | FERMT2 interactions | 3.61e-04 | 189 | 100 | 6 | int:FERMT2 | |
| Cytoband | 6p21.3 | 2.61e-04 | 250 | 103 | 5 | 6p21.3 | |
| Cytoband | 2p23 | 6.63e-04 | 17 | 103 | 2 | 2p23 | |
| Cytoband | 20q13.3 | 9.22e-04 | 20 | 103 | 2 | 20q13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p21 | 9.80e-04 | 503 | 103 | 6 | chr6p21 | |
| GeneFamily | PDZ domain containing | 2.19e-06 | 152 | 71 | 7 | 1220 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 1.15e-03 | 13 | 71 | 2 | 685 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 9.82e-07 | 199 | 100 | 8 | M5893 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-07 | 178 | 102 | 7 | 51d2188406f04329311b2efd1108fc36617a860e | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.87e-06 | 160 | 102 | 6 | 33050dc646762dc7e9dcc4a12c618e1ba1ce5a4d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.25e-06 | 176 | 102 | 6 | 6c7edf1cb38644500bce6c5a1dd90bbe17415cdb | |
| ToppCell | NS-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.58e-06 | 179 | 102 | 6 | 65a96bee7bc28f5bfc20f0fd92bcc0ab2eb5e06c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.69e-06 | 180 | 102 | 6 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.69e-06 | 180 | 102 | 6 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | COVID-19-kidney-CD-IC-B|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.94e-06 | 182 | 102 | 6 | ee6a8c356bbbdae55e4ea858337e079491f9f4aa | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-hematologic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.06e-06 | 183 | 102 | 6 | 1db466cf757813322db1cdcc0bf1d91c062fd9de | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-06 | 185 | 102 | 6 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | COVID-19-kidney-CD-IC-B|kidney / Disease (COVID-19 only), tissue and cell type | 4.60e-06 | 187 | 102 | 6 | ce05b89860573fe0356102e2998d1ef6d1968034 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.04e-06 | 190 | 102 | 6 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D175|Adult / Lineage, Cell type, age group and donor | 5.35e-06 | 192 | 102 | 6 | 733491e932350e3c216a626cc49c3cd3fe970a82 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.51e-06 | 193 | 102 | 6 | 305e15ee467826ee08b2617c69f250ad39c11b19 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.51e-06 | 193 | 102 | 6 | be75abfdf5301cf33df8ee9ed92504d44fdf19a6 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.51e-06 | 193 | 102 | 6 | dd376664906caccc9c2065f8e7a364509e18a5cc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-06 | 197 | 102 | 6 | c10dd1aaec01fb662eac83dfde90e3e426665d65 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.20e-06 | 197 | 102 | 6 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 6.20e-06 | 197 | 102 | 6 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-06 | 197 | 102 | 6 | 2844dbcd0a673ed81c99920aa45858651a00736d | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 6.38e-06 | 198 | 102 | 6 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.38e-06 | 198 | 102 | 6 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.38e-06 | 198 | 102 | 6 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_3|COVID-19_Severe / Disease condition and Cell class | 6.57e-06 | 199 | 102 | 6 | ffb2ef9b7006cbed0f43637af040719b9776cbd5 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-05 | 136 | 102 | 5 | 7cd22169fb71c6caf9feb203ad98be8480a54fba | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-05 | 137 | 102 | 5 | 81cdb216e6c81acf9c2072f9d39e1a42612e1258 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-05 | 146 | 102 | 5 | ec1f793409d1a81c0f9323eb3c82ffe01dae0e44 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-05 | 150 | 102 | 5 | 87968ce885a4959616f0321f58517fe8029ba1b1 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-05 | 152 | 102 | 5 | d279592c501fca9cb474ad916fea32282e6969cb | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-05 | 152 | 102 | 5 | 3b59143b2b4ee24eb6378f87ff568124193256e9 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Nts|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.97e-05 | 77 | 102 | 4 | dbbefd2dfa4c345172cb5a995952e3682fbadf92 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.68e-05 | 163 | 102 | 5 | d005115aa1e1458b51de7eb719794617a4168608 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.13e-05 | 167 | 102 | 5 | a54b8e03987a7b067173121902e1811a3d003692 | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor|lymph-node_spleen / Manually curated celltypes from each tissue | 4.13e-05 | 167 | 102 | 5 | cb396f3edb9e8fdc316091e8e193dbba50e0be0c | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.25e-05 | 168 | 102 | 5 | 6a233045638cb83dab64789b996b7598c325001e | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 4.37e-05 | 169 | 102 | 5 | 84b898a9fd8ced67c6a501d5cef6416f519902c4 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.30e-05 | 176 | 102 | 5 | 7292e014b8f697f0c2e9f47c48333de95cb44a69 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.30e-05 | 176 | 102 | 5 | 88ca2f83d8301633232735f39b0683efe49d0b86 | |
| ToppCell | PBMC-Mild-cDC_11|Mild / Compartment, Disease Groups and Clusters | 5.45e-05 | 177 | 102 | 5 | 974305e4c0eff90134c4e58cf11b955d1eee0501 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.90e-05 | 180 | 102 | 5 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 6.06e-05 | 181 | 102 | 5 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.22e-05 | 182 | 102 | 5 | 587636c0f127231de21acd8aa632b74ff22ca8c2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.22e-05 | 182 | 102 | 5 | adfadd7893e74b3002f13f00875e3667d3493e0c | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.38e-05 | 183 | 102 | 5 | 6f8f997ffc9eaebca2683de125b6069d07c07d26 | |
| ToppCell | critical-Epithelial-Ionocyte|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.55e-05 | 184 | 102 | 5 | 58d36577eff814d46d72f031f3533d71549e3d6e | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.72e-05 | 185 | 102 | 5 | c4bf3ac684c1a8876b51f7af4d3a62dc47e961ee | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-05 | 185 | 102 | 5 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-05 | 185 | 102 | 5 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-05 | 185 | 102 | 5 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.89e-05 | 186 | 102 | 5 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.89e-05 | 186 | 102 | 5 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | Myeloid-B_(Activated_Macrophage)|World / shred on cell class and cell subclass (v4) | 6.89e-05 | 186 | 102 | 5 | 33d731a7883d75e4e7db83b641cdb1e9a39938bf | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.89e-05 | 186 | 102 | 5 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.89e-05 | 186 | 102 | 5 | ed0a91f47e77fe21d4c7678d0f2a7c5f97d63dda | |
| ToppCell | severe_influenza-RBC|World / disease group, cell group and cell class (v2) | 7.07e-05 | 187 | 102 | 5 | f846750575f318503d21ade30f5bfd2e1d4c84af | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-05 | 187 | 102 | 5 | f3ef3f5a761f8306edc39bf16e76e44aae6fa7f6 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-05 | 187 | 102 | 5 | 1669df899b1759c338ffce196fe009840123cfcd | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.25e-05 | 188 | 102 | 5 | e751cff2ac8fbc1487766c1871fcc5d1005286b0 | |
| ToppCell | Endothelial-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.25e-05 | 188 | 102 | 5 | 0824d567356d360fd8e78e840c30529c139f98a1 | |
| ToppCell | Control-B_intermediate-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.43e-05 | 189 | 102 | 5 | 11cb9a16f1de8f60af2073ed7ea6d4f41c02f299 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.43e-05 | 189 | 102 | 5 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.43e-05 | 189 | 102 | 5 | 4dc32b463546bbe7250dddd281b92ad17ec22da1 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.43e-05 | 189 | 102 | 5 | 0d06bf0d7191d13a1c4f30a7881e7ea1093bfd6f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.43e-05 | 189 | 102 | 5 | 532aaf02b364c5c4f58a2021c7c21d86df3875c9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.62e-05 | 190 | 102 | 5 | b3bccf4dd95e986db3cee324a6737f5fcc22e8e5 | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 7.81e-05 | 191 | 102 | 5 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| ToppCell | facs-Heart-LA-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.00e-05 | 192 | 102 | 5 | 14a816ef116aa992f86edab411f043cf7d07fe04 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.00e-05 | 192 | 102 | 5 | f7e7491426bbd6ed29a465b58bf67acb93dbb90a | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 8.00e-05 | 192 | 102 | 5 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | facs-Heart-LA-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.00e-05 | 192 | 102 | 5 | 847822514d747a21d5eb40e04ba9a023fd32bd65 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.20e-05 | 193 | 102 | 5 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.20e-05 | 193 | 102 | 5 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.20e-05 | 193 | 102 | 5 | a5695ce2e24a62026ae28f3dea07ca4a435206b8 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-naive_regulatory_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.20e-05 | 193 | 102 | 5 | 28138c35ea82c6b2163f0cae045ca55859347c73 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.20e-05 | 193 | 102 | 5 | 5a201ee6f132357c9aacfbad3ae56ed9854c25fd | |
| ToppCell | NS-critical-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.40e-05 | 194 | 102 | 5 | 2172d951896265243d14996eacce5aab5e14e26e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.40e-05 | 194 | 102 | 5 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-mesenchymal_progenitor_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.40e-05 | 194 | 102 | 5 | 3d25d6ebec8d1b6001f602257cd15b3ba04cf0c1 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.40e-05 | 194 | 102 | 5 | ff19fb5bc7feae3e774ef4ab720beb9dec219f45 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.61e-05 | 195 | 102 | 5 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.61e-05 | 195 | 102 | 5 | e06ff785c5542c86c335d956799e03f7ae8345a4 | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Control / Disease condition and Cell class | 8.61e-05 | 195 | 102 | 5 | 0fea64ee3eedf3929abb0dd9c5f5fc72f181eed9 | |
| ToppCell | ASK452|World / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.61e-05 | 195 | 102 | 5 | 7efd9d3a3f5e7dfe9698a4143ce4a0f9bf3a862c | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Secretory|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.82e-05 | 196 | 102 | 5 | 70384c1da9baed843f414cfd1403ddd586a2db07 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.82e-05 | 196 | 102 | 5 | fe8d3f45a64323947c36b127355d5940eb56c0ca | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.82e-05 | 196 | 102 | 5 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.82e-05 | 196 | 102 | 5 | 526d037bb12d81f1c235c60ddc787fbad0bbad77 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.82e-05 | 196 | 102 | 5 | e224338490691d92c1f70b57112fabdcc92b06a9 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.03e-05 | 197 | 102 | 5 | fb272c9c60ee3d980e528044dc567b4925a23da6 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.03e-05 | 197 | 102 | 5 | 61c0d78b29dc4ad8a84172cbfcdab03f31351d0e | |
| ToppCell | control-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.03e-05 | 197 | 102 | 5 | df2fe36cb96e2565a9d21c24cb4e451e8befd4be | |
| ToppCell | normal_Lung-T/NK_cells-CD4+_Th|T/NK_cells / Location, Cell class and cell subclass | 9.03e-05 | 197 | 102 | 5 | 80b3902ceea242148a1f1707c633f66afedf5183 | |
| ToppCell | tumor_Lung-T/NK_cells-CD4+_Th|T/NK_cells / Location, Cell class and cell subclass | 9.03e-05 | 197 | 102 | 5 | 0379d67beeba5864b5ffe5d282643204a112754f | |
| ToppCell | ASK452-Epithelial-Transformed_epithelium|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.03e-05 | 197 | 102 | 5 | b22a79a5922c865a360e2afc5506a08a512fa76a | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.03e-05 | 197 | 102 | 5 | 3cd1c816bc7a57278b2ef615b69545356ab8f522 | |
| ToppCell | Adult-Immune|Adult / Lineage, Cell type, age group and donor | 9.25e-05 | 198 | 102 | 5 | 9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.25e-05 | 198 | 102 | 5 | d5e525d2f2226d06a3fb985ce3a33555ff4b2e7b | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Gpr50|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.27e-05 | 103 | 102 | 4 | d8965b338b90ddc0686ea0d94e9a330128566c39 | |
| ToppCell | BAL-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters | 9.47e-05 | 199 | 102 | 5 | c55181bdec8952b54198f0d4c9c5c84265b16572 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Transitional_AT2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 9.47e-05 | 199 | 102 | 5 | cd581d7330b471431ef427f8a4f5be553f70e068 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte|COVID-19_Severe / Disease condition and Cell class | 9.47e-05 | 199 | 102 | 5 | ea1e2ccde3930fab6d04a9bf130837455c742474 | |
| Drug | Hydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; PC3; HT_HG-U133A | 2.38e-06 | 197 | 99 | 8 | 7309_DN | |
| Disease | reticulocyte measurement | GPHN FLNA FLNB FOXK2 VWF SEPTIN9 HECTD4 LARP1 MIDEAS JMJD1C ERAL1 AHNAK CPEB4 PKLR DDX39A ATP2B1 DDX39B | 4.05e-08 | 1053 | 95 | 17 | EFO_0010700 |
| Disease | reticulocyte count | FLNB FOXK2 VWF SEPTIN9 HECTD4 LARP1 MIDEAS JMJD1C ERAL1 AHNAK CPEB4 PKLR DDX39A ATP2B1 DDX39B | 1.22e-06 | 1045 | 95 | 15 | EFO_0007986 |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 3.07e-05 | 3 | 95 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 3.07e-05 | 3 | 95 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | von Willebrand factor measurement, coronary artery disease | 4.08e-05 | 118 | 95 | 5 | EFO_0001645, EFO_0004629 | |
| Disease | venous thromboembolism, fibrinogen measurement | 6.62e-05 | 67 | 95 | 4 | EFO_0004286, EFO_0004623 | |
| Disease | fibrinogen measurement, coronary artery disease | 1.44e-04 | 154 | 95 | 5 | EFO_0001645, EFO_0004623 | |
| Disease | serum gamma-glutamyl transferase measurement | JCAD DLG5 CDC42BPA EML4 SEPTIN9 HECTD4 DYRK1A JMJD1C AHNAK ACSS3 BAHCC1 | 1.73e-04 | 914 | 95 | 11 | EFO_0004532 |
| Disease | forced expiratory volume | 2.30e-04 | 789 | 95 | 10 | EFO_0004314 | |
| Disease | female breast cancer (is_implicated_in) | 2.84e-04 | 8 | 95 | 2 | DOID:0050671 (is_implicated_in) | |
| Disease | margarate 17:0 measurement | 3.64e-04 | 9 | 95 | 2 | EFO_0021066 | |
| Disease | Epilepsy | 4.33e-04 | 109 | 95 | 4 | C0014544 | |
| Disease | disorder of pharynx | 4.44e-04 | 46 | 95 | 3 | MONDO_0020592 | |
| Disease | coronary artery disease | DAB2IP JCAD DPYD HECTD4 CFB PHF1 IGF2BP1 LRP1 PLEKHH2 ATP2B1 TNXB ALK | 4.51e-04 | 1194 | 95 | 12 | EFO_0001645 |
| Disease | hypertension | 4.83e-04 | 307 | 95 | 6 | EFO_0000537 | |
| Disease | factor VIII measurement, coronary artery disease | 4.96e-04 | 113 | 95 | 4 | EFO_0001645, EFO_0004630 | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 6.63e-04 | 12 | 95 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | Herpes Zoster, response to tofacitinib | 6.63e-04 | 12 | 95 | 2 | EFO_0006510, EFO_0600024 | |
| Disease | interleukin 12 measurement | 6.74e-04 | 53 | 95 | 3 | EFO_0004753 | |
| Disease | Malignant neoplasm of breast | 6.76e-04 | 1074 | 95 | 11 | C0006142 | |
| Disease | Ischemic stroke, fibrinogen measurement | 7.51e-04 | 55 | 95 | 3 | EFO_0004623, HP_0002140 | |
| Disease | mean corpuscular hemoglobin concentration | FOXK2 HECTD4 LARP1 MIDEAS RAB10 BBS7 ERAL1 HECW2 CPEB4 KIF3C DDX39A | 8.53e-04 | 1105 | 95 | 11 | EFO_0004528 |
| Disease | fibrinogen measurement, factor VII measurement | 8.77e-04 | 58 | 95 | 3 | EFO_0004619, EFO_0004623 | |
| Disease | cognitive function measurement, self reported educational attainment | 1.03e-03 | 355 | 95 | 6 | EFO_0004784, EFO_0008354 | |
| Disease | ascending aortic diameter | 1.11e-03 | 140 | 95 | 4 | EFO_0021787 | |
| Disease | peak expiratory flow | 1.15e-03 | 498 | 95 | 7 | EFO_0009718 | |
| Disease | pancreatitis | 1.20e-03 | 16 | 95 | 2 | EFO_0000278 | |
| Disease | Coronary Arteriosclerosis | 1.22e-03 | 65 | 95 | 3 | C0010054 | |
| Disease | Coronary Artery Disease | 1.22e-03 | 65 | 95 | 3 | C1956346 | |
| Disease | aortic measurement | 1.33e-03 | 251 | 95 | 5 | EFO_0020865 | |
| Disease | attention function measurement | 1.36e-03 | 148 | 95 | 4 | EFO_0007636 | |
| Disease | gait measurement | 1.43e-03 | 150 | 95 | 4 | EFO_0007680 | |
| Disease | Age-related macular degeneration | 1.52e-03 | 18 | 95 | 2 | cv:C0242383 | |
| Disease | tonsillectomy risk measurement | 1.55e-03 | 260 | 95 | 5 | EFO_0007924 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 1.69e-03 | 19 | 95 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | factor VIII measurement, Ischemic stroke | 1.69e-03 | 19 | 95 | 2 | EFO_0004630, HP_0002140 | |
| Disease | Colorectal Carcinoma | 1.95e-03 | 702 | 95 | 8 | C0009402 | |
| Disease | Schizophrenia | 2.19e-03 | 883 | 95 | 9 | C0036341 | |
| Disease | Epilepsy, Cryptogenic | 2.38e-03 | 82 | 95 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 2.38e-03 | 82 | 95 | 3 | C0751111 | |
| Disease | Aura | 2.38e-03 | 82 | 95 | 3 | C0236018 | |
| Disease | response to clopidogrel, cardiovascular event measurement | 2.48e-03 | 23 | 95 | 2 | EFO_0006919, GO_1903493 | |
| Disease | descending aortic diameter | 2.91e-03 | 88 | 95 | 3 | EFO_0021788 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LGEKPLRIIGVKVHP | 186 | Q9BSJ8 | |
| GKERHKLVLPVPADG | 246 | Q9P281 | |
| PIHKESGPGEELKIN | 321 | Q8IWZ6 | |
| NVGGKVIHLVERAPP | 76 | P46379 | |
| LKKNCPHIVVGTPGR | 161 | Q13838 | |
| KKNCPHVVVGTPGRI | 161 | O00148 | |
| GRIKPKPVEVQVVTH | 356 | Q9P1U1 | |
| VDVPKLEGDLKGPHV | 2406 | Q09666 | |
| KGPKVGIDTPDIDIH | 4556 | Q09666 | |
| TVSHQKGKPVPRIAE | 856 | Q12882 | |
| KPPGTRKLHNILGVE | 416 | Q13627 | |
| KHGPSPGVRAEKETI | 386 | Q9H4D0 | |
| PEKEGGLPRHVGNKT | 531 | P20020 | |
| VVPKGKGEQIAREHG | 131 | P61026 | |
| KIEEHAPGVPKILVG | 111 | Q8WXH6 | |
| KIEEHAPGVPKILVG | 111 | P0C0E4 | |
| KHRLVVLVKDNGEPP | 636 | Q9Y5E4 | |
| PGKVLNGEKVDVRPA | 146 | Q8N684 | |
| GLGVETERPKQKTEP | 101 | Q96DU7 | |
| GIVKLKPHEEPLRSE | 76 | P43378 | |
| ARPGQDIRPIGHDIK | 451 | Q9NQX3 | |
| HGPGEQQKRKIVLDP | 251 | P00751 | |
| RELKPGGANIPVTEK | 1386 | Q9P2P5 | |
| GDSPELKPRAVHKQG | 976 | Q5VWQ8 | |
| LQAEEHGGLVRKKPP | 16 | Q6PKG0 | |
| SKVRPPVGGISVKEH | 1991 | Q14667 | |
| PNNGRIHVGKVLPKT | 116 | Q9BZ81 | |
| HREVKVKVEPIPAIG | 521 | Q01167 | |
| GPKEEVKLETHIRVP | 481 | Q9NZI8 | |
| GLDKPRAITVHPEKG | 2006 | Q07954 | |
| LGAHPGPKREVVKGE | 791 | Q9P266 | |
| KHQPESEGLVGKIPE | 1151 | Q15652 | |
| AEAVKIERTHPGLPK | 736 | Q5VYM1 | |
| PGKRLELKENPETGV | 161 | O14782 | |
| HPQKVKVFGPGVERS | 741 | O75369 | |
| LDTPGIISPGKQKRH | 166 | O75616 | |
| PKEAPGVSRHLVVKE | 641 | Q5H8C1 | |
| EEPRHVKVQKGSEPL | 1346 | Q8TDM6 | |
| VPPEHGKRLERLAKG | 211 | O75164 | |
| PGGIGTREVHNKLEK | 216 | Q99583 | |
| LGPEGHGIKIISKIE | 301 | P30613 | |
| PKKPGHILVLLDTEG | 86 | P32455 | |
| GKEQHPVKVVSTKRP | 3336 | Q9Y4D8 | |
| IKGIVKDIIHDPGRG | 41 | P62917 | |
| KSPSDVIRKPQGHIE | 736 | Q8IVE3 | |
| PKIQRGPKHLKVQVG | 1171 | Q96RW7 | |
| KTPHSGAQLGVPREK | 1086 | Q86Y26 | |
| EEEIKKHGSNPVGLP | 416 | A0JP26 | |
| KHRLVVLVKDNGEPP | 636 | Q9Y5E5 | |
| VIVRSKPPKGQGAEH | 21 | Q96M91 | |
| VGSTLQPPKHRKGRQ | 1726 | O95996 | |
| HPDRVKARGPGLEKT | 671 | P21333 | |
| FGRPVVVPHGKEKEA | 441 | Q7Z7M9 | |
| HKLIRLEEGVPPGTV | 511 | P55283 | |
| PHGESEQIGVIPSKK | 551 | Q92796 | |
| RHQKIIEEAPAPGIK | 281 | Q96RQ3 | |
| HPEALKREKAGGPQL | 161 | Q6PJG2 | |
| VKVHTVPKPGKGADL | 186 | O95260 | |
| EPVKQHIPLRNLGGK | 11 | Q17RS7 | |
| VIVQERKDTKPGVPH | 346 | Q6PII3 | |
| KPLVKEGGDRPRHIS | 711 | Q17RY0 | |
| AGVDKDGKPLQPVVH | 326 | Q32P44 | |
| GVDKDGRPLQPHVRV | 331 | Q9HC35 | |
| PKAPLGGIHISETKQ | 901 | Q14689 | |
| PGVKVIIAHTETKGP | 1366 | Q14689 | |
| GEKEIPHIKVGPEET | 111 | Q16478 | |
| EEEIKKHGSNPVGLP | 416 | B2RU33 | |
| KGKVEELGPPSAVRN | 381 | O43189 | |
| EEEIKKHGSNPVGLP | 416 | Q86YR6 | |
| VVKRKSALGPGVPHI | 291 | Q9GZS1 | |
| HKSEESIVPRPEGKG | 416 | Q96PL5 | |
| KKIRLVSHPEEPVAG | 876 | Q9NZ71 | |
| DHKVKVTPLGNPDRP | 291 | Q8NEY4 | |
| GIKKHRVTLPGQEEP | 21 | Q9BTM9 | |
| RTEQEKSGVPHIPKI | 621 | Q8TEU7 | |
| DKRTPIVIIKQGHEP | 686 | Q9Y6U3 | |
| HGPQVLGSEVKVKPP | 191 | O15353 | |
| PPTIKGVKHLKGQNE | 76 | Q8WVI7 | |
| KKKERGHTVTEPIQP | 426 | O15446 | |
| GLKRAEVLGHKTPEP | 131 | Q9UHD8 | |
| LKGGREHGEPLVITK | 41 | Q13796 | |
| VVDVGSEPRAPKLHK | 106 | Q13228 | |
| SQPEPLVVKGKRVAG | 371 | Q13228 | |
| EHDPVKPRQLPKTIG | 306 | Q9Y253 | |
| QPAGKAEGIREPKVT | 681 | P46087 | |
| EGHVRIPKPAGVKKG | 1086 | Q5VT25 | |
| PPKRDEERGKTQGKH | 941 | O15047 | |
| PIAKKEPHDRGNLGL | 1521 | Q9UM73 | |
| VPEEVGLKGHLPKLQ | 2226 | Q8IVF2 | |
| VPEGAGLKEHLPKVE | 3711 | Q8IVF2 | |
| VPEEAGLKGHLPKVQ | 3876 | Q8IVF2 | |
| VPEGASLKGHLPKVQ | 4041 | Q8IVF2 | |
| VVGKEDPLKGHVPLA | 586 | Q9H6R3 | |
| PIILIDGKDKTGVHR | 396 | Q7Z7G1 | |
| SAVVPEHGQKTPRKI | 71 | Q53QW1 | |
| PVVFVKQRKIGGHGP | 121 | Q16881 | |
| RSHIKEEGPEGPQRI | 451 | A0A0J9YY54 | |
| SHIKEEGPEGPQRIV | 576 | A0A0J9YY54 | |
| EKRQLGGKDGPPHQV | 71 | Q2NL82 | |
| KKKVIVIPVGIGPHA | 1406 | P04275 | |
| PDGKREKEVVLPNVH | 736 | Q13009 | |
| PKAVRVPGHEDGVTI | 3101 | P22105 | |
| HGEDRKVVFQKGPPE | 91 | Q6ZNM6 | |
| GRTAPPSKVVHLGDK | 751 | Q8IZH2 | |
| GGVDHLPVKILQPAK | 16 | Q86V86 | |
| FRGNKIIHIGEKPPA | 271 | P0CI00 | |
| KIKHPIGTRKGPLEV | 11 | Q6P2C0 | |
| GIKVPIEAKINHGRE | 136 | P63123 | |
| HCGEKPLKRQEGRVP | 131 | Q96HQ0 | |
| GLEHGQPPIERKVIE | 171 | P51784 | |
| PGPHEKGLVLQELKV | 136 | Q9NR64 | |
| AGRSLGEHLPKIQKP | 271 | Q13094 | |
| GKPVLGEHPKLEVII | 656 | P57103 |